Pharmaceutical Sciences Faculty Publications

Document Type

Article

Publication Date

1-1-2012

Journal Title

PLoS One

ISSN

1932-6203

Volume

7

Issue

12

First Page

51407

Last Page

51407

DOI

10.1371/journal.pone.0051407

PubMed ID

23236496

PubMed Central® ID

PMC3517524

Abstract

Histone methylation regulates normal stem cell fate decisions through a coordinated interplay between histone methyltransferases and demethylases at lineage specific genes. Malignant transformation is associated with aberrant accumulation of repressive histone modifications, such as polycomb mediated histone 3 lysine 27 (H3K27me3) resulting in a histone methylation mediated block to differentiation. The relevance, however, of histone demethylases in cancer remains less clear. We report that JMJD3, a H3K27me3 demethylase, is induced during differentiation of glioblastoma stem cells (GSCs), where it promotes a differentiation-like phenotype via chromatin dependent (INK4A/ARF locus activation) and chromatin independent (nuclear p53 protein stabilization) mechanisms. Our findings indicate that deregulation of JMJD3 may contribute to gliomagenesis via inhibition of the p53 pathway resulting in a block to terminal differentiation.

Keywords

Blotting, cell differentiation, cell transformation, neoplastic, DNA primers, glioblastoma, histones, immunohistochemistry, immunoprecipitation, jumonji, mass spectrometry

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.